WATER FOR INJECTIONS water for injections 20 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

water for injections water for injections 20 ml solution for injection ampoule

interpharma pty ltd - water for injections, quantity: 20 ml - injection, solution - excipient ingredients: - water for injections is used to dissolve or dilute substances or preparations for parenteral administration. water for injections may also be used as an irrigating solution for small wounds or during minor surgical procedures.

WATER FOR INJECTIONS water for injections 10 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

water for injections water for injections 10 ml solution for injection ampoule

interpharma pty ltd - water for injections, quantity: 10 ml - injection, solution - excipient ingredients: - water for injections is used to dissolve or dilute substances or preparations for parenteral administration. water for injections may also be used as an irrigating solution for small wounds or during minor surgical procedures.

WATER FOR INJECTIONS water for injections 5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

water for injections water for injections 5 ml solution for injection ampoule

interpharma pty ltd - water for injections, quantity: 5 ml - injection, solution - excipient ingredients: - water for injections is used to dissolve or dilute substances or preparations for parenteral administration. water for injections may also be used as an irrigating solution for small wounds or during minor surgical procedures.

WOCKHADRINE ephedrine hydrochloride 30 mg/10 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

wockhadrine ephedrine hydrochloride 30 mg/10 ml solution for injection ampoule

interpharma pty ltd - ephedrine hydrochloride, quantity: 30 mg - injection, solution - excipient ingredients: sodium chloride; sodium citrate; citric acid; water for injections - wockhadrine injection is indicated in the treatment of hypotension secondary to spinal anaesthesia.

CABAZITAXEL EVER PHARMA cabazitaxel 60 mg/6 mL concentrated solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cabazitaxel ever pharma cabazitaxel 60 mg/6 ml concentrated solution for injection vial

interpharma pty ltd - cabazitaxel, quantity: 60 mg - injection, concentrated - excipient ingredients: polysorbate 80; ethanol absolute; macrogol 300; citric acid - cabazitaxel ever pharma in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen.

CABAZITAXEL EVER PHARMA cabazitaxel 50 mg/5 mL concentrated solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cabazitaxel ever pharma cabazitaxel 50 mg/5 ml concentrated solution for injection vial

interpharma pty ltd - cabazitaxel, quantity: 50 mg - injection, concentrated - excipient ingredients: polysorbate 80; ethanol absolute; macrogol 300; citric acid - cabazitaxel ever pharma in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen.

CABAZITAXEL EVER PHARMA cabazitaxel 45 mg/4.5 mL concentrated solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cabazitaxel ever pharma cabazitaxel 45 mg/4.5 ml concentrated solution for injection vial

interpharma pty ltd - cabazitaxel, quantity: 45 mg - injection, concentrated - excipient ingredients: polysorbate 80; ethanol absolute; macrogol 300; citric acid - cabazitaxel ever pharma in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen.

ORALTAG- iohexol for solution United States - English - NLM (National Library of Medicine)

oraltag- iohexol for solution

interpharma praha, a.s. - iohexol (unii: 4419t9mx03) (iohexol - unii:4419t9mx03) - iodine 4.5 g - oraltag is indicated for use in computed tomography of the abdomen and pelvis to opacify bowel loops and delineate between normal loops and adjacent organs or areas of suspected pathology. limitations of use oraltag is not indicated for diagnostic examination of the gastrointestinal tract. oraltag is contraindicated in patients with a known hypersensitivity to iodinated contrast agents, including iohexol [see warnings and precautions (5.2)] . risk summary there are no human data on risks associated with the use of oraltag during pregnancy. the background risk in the u.s. general population of major birth defects is 2% to 4% and risk of miscarriage is 15% to 20% of clinically recognized pregnancies. in animal reproduction studies, no evidence of fetal harm was observed with intravenous administration of iohexol to rats and rabbits at doses up to 100 times the maximum recommended human intravenous dose. risk summary iohexol administered intravenously is present in human

IIrrigation fluid, medical/surgical procedure Australia - English - Department of Health (Therapeutic Goods Administration)

iirrigation fluid, medical/surgical procedure

interpharma pty ltd -

Sterile isotonic sodium chloride solution pack, inhalation therapy Australia - English - Department of Health (Therapeutic Goods Administration)

sterile isotonic sodium chloride solution pack, inhalation therapy

interpharma pty ltd -